Evaluating Need for Additional Imaging and Biopsy After Oncoplastic Breast-Conserving Surgery
| Autor: | Christina Weed, Janie Grumley, Flavio G. Rocha, Ruby Laskin, Angelena Crown |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
medicine.diagnostic_test business.industry medicine.medical_treatment Oncoplastic Surgery 03 medical and health sciences 0302 clinical medicine Oncology 030220 oncology & carcinogenesis Biopsy Cohort medicine Breast-conserving surgery 030211 gastroenterology & hepatology Surgery Radiology Surveillance imaging Single institution business |
| Zdroj: | Annals of Surgical Oncology. 27:3650-3656 |
| ISSN: | 1534-4681 1068-9265 |
| DOI: | 10.1245/s10434-020-08500-y |
| Popis: | Breast-conserving therapy (BCT) using oncoplastic surgery (OPS) allows for larger resections and improved aesthetics though volume redistribution and tissue rearrangement. Data regarding the impact of OPS on surveillance imaging and need for additional biopsies are limited. This observational cohort underwent BCT at a single institution from 2009 to 2018; standard breast-conserving surgery (BCS) was the predominant approach until OPS was introduced in 2012. Rates of imaging beyond standard diagnostic views, as well as rates of biopsy following both approaches, are reported. A total of 422 consecutive patients were identified. The OPS group comprised 205 patients and the BCS group included 217 patients. There was no difference in need for additional imaging between groups (BCS: 58 patients [26.7%] vs. OPS: 53 patients [25.9%]; p = 0.91). When additional imaging was required, it was on the ipsilateral side in 35 (60.3%) BCS patients compared with 24 (45.3%) OPS patients (p = 0.21). The need for biopsy was higher in the BCS group (BCS: 41 patients [18.9%] with 47 total biopsies vs. OPS: 20 patients [9.3%] with 22 total biopsies; p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink